ProtoKinetix, Inc.

ProtoKinetix, Inc. is a research and development stage biotechnology company focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs), which are trademarked as AAGPs®. These are also referred to as anti-aging glycoproteins. The company is directing significant efforts towards the practical side of commercial validation for AAGPs®. ProtoKinetix identifies numerous commercial applications for AAGPs® in large markets, such as targeted healthcare solutions. The company is actively collaborating with researchers, business leaders, advisors, and commercial entities to bring AAGP® to market. ProtoKinetix was originally incorporated as RJV Network, Inc. on December 23, 1999, in Nevada, with the initial purpose of developing an internet-based listing site for commercial real estate. In July 2003, the company entered into an assignment of license agreement with BioKinetix Research, Incorporated, acquiring rights to proprietary technologies for the creation and commercialization of "superantibodies." On July 8, 2003, the company changed its name to "ProtoKinetix, Incorporated." The company's executive offices are located at 109 W Main St, Dalton, Ohio 44618.